(NYSE: SNN) Smith & Nephew's forecast annual revenue growth rate of 7.81% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.42%.
Smith & Nephew's revenue in 2026 is $5,810,000,134.On average, 22 Wall Street analysts forecast SNN's revenue for 2026 to be $5,779,682,064,810, with the lowest SNN revenue forecast at $5,495,305,908,546, and the highest SNN revenue forecast at $6,032,460,870,378. On average, 19 Wall Street analysts forecast SNN's revenue for 2027 to be $6,079,856,896,422, with the lowest SNN revenue forecast at $5,733,163,742,952, and the highest SNN revenue forecast at $6,380,031,728,034.
In 2028, SNN is forecast to generate $6,393,197,290,824 in revenue, with the lowest revenue forecast at $6,029,827,757,820 and the highest revenue forecast at $6,722,336,360,574.